Discontinuation of dasatinib or nilotinib in chronic myeloid leukemia: interim analysis of the STOP 2G-TKI study (Q40434005)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Discontinuation of dasatinib or nilotinib in chronic myeloid leukemia: interim analysis of the STOP 2G-TKI study |
scientific article |
Statements
1 reference
Discontinuation of dasatinib or nilotinib in chronic myeloid leukemia: interim analysis of the STOP 2G-TKI study (English)
1 reference
Franck E Nicolini
1 reference
Michel Tulliez
1 reference
Joelle Guilhot
1 reference
Agnès Guerci-Bresler
1 reference
Martine Gardembas
1 reference
Valérie Coiteux
1 reference
Gaelle Guillerm
1 reference
Laurence Legros
1 reference
Gabriel Etienne
1 reference
Jean-Michel Pignon
1 reference
Bruno Villemagne
1 reference
Martine Escoffre-Barbe
1 reference
Jean-Christophe Ianotto
1 reference
Aude Charbonnier
1 reference
Hyacinthe Johnson-Ansah
1 reference
Marie-Pierre Noel
1 reference
Philippe Rousselot
1 reference
François-Xavier Mahon
1 reference
France Intergroupe des Leucémies Myéloïdes Chroniques
1 reference
8 December 2016
1 reference
Identifiers
1 reference